Srinivasan Jain should be arrested for creating panic among public regarding Covaxin efficacy.Is he lobbying as agent for Pfizer vaccine joining hands with opposition parties. This is what an angry Indian on social media tweeted after the senior journalist tweeted a misleading, twisted words about India’s COVID-19– vaccine innovation quoting an interaction with Dr. NK Arora, Head of Govt. of India, Vaccine Advisory Panel.
Sreenivasan Jain retracted an hour and 30 minutes later, and wrote a clarification ‘clarified’ that these batches were not administered.
What did Sreeninvasan Jain Tweet about Bharat Biotech COVAXIN?
NDTV Editor Sreenivasan Jain, who for a moment of glory, tweeted baseless allegations against vaccine quality which is due process followed at labs ( which has not even gone out for inoculation) has been caught spreading fake and fear mongering news on many occasions in the past, now he was caught spreading fake news about Bharat Biotech’s indigenously developed Covid vaccine Covaxin.
On Monday (August 2), he tweeted, “Breaking: the head of the Govt’s vaccine advisory panel Dr NK Arora tells me initial batches of Covaxin ‘were not of the right quality.”
He tweeted this at 9:27 pm.
Sreeninvasn Jain Integrity in Question – As Social Media Turns Angry against his tweet
Dr NK Arora had discussed the quality check process of Covaxin in his programme Reality Check.
There was a social media protest about the fake news spread by Jain.
At 10:51 pm, Jain put out a clarification “As per Dr Arora, these doses from the initial batches with quality issues (manufactured at the Bangalore plant) were never sent out. The new batches have passed quality checks, he says.”
He added, “This was in response to questions on Covaxin falling short of targets. He said production was affected because of quality issues in initial batches, now remedied.”
Dr NK Arora very explicitly said on the show that he was discussing the initial quality check process at the Bharat Biotech plant in Bengaluru.
But, Jain tweeted it, saying there were quality issues with the initial doses of Covaxin.
Sreenivasan Jain Succumbs to backlash for his tweet Deletes the Tweet and offered an apology
Meanwhile, Twitter has not yet flagged Jain’s tweet as misleading. Why let facts get into the way of mischief that has potential to derail India’s vaccination programme, which is the largest in the world.
COVAXIN is the only vaccine today that works against variants of concernt. Its data has also been published in 11 publications including 3 peer-reviewed widely acknowledged scientific publications. Moreover, the vaccine demonstrated robust efficacy and strong immune ressponse, helping people to counter severriaty and and minimising hospitalisation.
Actor Preity Zinta : Am happy I took #Covaxin
Final Analysis of COVAXIN trials
- Efficacy analysis demonstrates COVAXIN® to be 77.8% effective against symptomatic COVID19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus
106 in the placebo group
- Efficacy analysis demonstrates COVAXIN® to be 93.4% effective against severe symptomatic
- Safety analysis demonstrates adverse events reported were similar to placebo, with 12% of subjects experiencing commonly known side effects and less than 0.5% of subjects feeling
serious adverse events
- Efficacy data demonstrates 63.6% protection against asymptomatic COVID-19
- Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta variant